Cutaneous marginal zone B-cell lymphoma in the setting of fluoxetine therapy: A hypothesis regarding pathogenesis based on in vitro suppression of T-cell-proliferative response

Journal of Cutaneous Pathology

Volumn 33, Issue 7, 2006, Pages 522-528

  Breza Jr , Thomas S ^a   Zheng, Pan ^b   Porcu, Pierluigi ^b   Magro, Cynthia M ^b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTICONVULSIVE AGENT; FLUOXETINE;

ADULT; ARTICLE; B CELL LYMPHOMA; BIOPSY; CASE REPORT; CELL PROLIFERATION; HUMAN; MALE; MICROSCOPY; MITOGENESIS; PATHOGENESIS; PERIPHERAL LYMPHOCYTE; PHENOTYPE; SKIN BIOPSY; SKIN LYMPHOMA; T LYMPHOCYTE;

ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOXETINE; HUMANS; IN SITU HYBRIDIZATION; LYMPHOCYTE ACTIVATION; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; PSEUDOLYMPHOMA; SKIN NEOPLASMS; T-LYMPHOCYTES;

EID: 33745875930     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2006.00475.x     Document Type: Article

References (23)

1. Crowson A, Magro C. Antidepressant therapy: a possible cause of atypical cutaneous lymphoid hyperplasia. Arch Dermatol 1995; 131: 925.
2. Halevy S, Sandbank M. Transformation of lymphocytoma cutis into malignant lymphoma in association with the sign of Leser-Trelat. Acta Derm Venereol 1987; 67: 172.
3. Kulow BF, Cualing H, Steele P, et al. Progression of cutaneous B-cell pseudolymphoma to cutaneous B-cell lymphoma. J Cutan Med Surg 2002; 6: 519.
4. Ploysangam T, Breneman D, Mutasim D. Cutaneous pseudolymphomas. J Am Acad Dermatol 1998; 38: 877.
5. Magro C, Crowson A. Drug induced immune dysregulation as a cause of atypical cutaneous lymphoid infiltrates. Hum Pathol 1996; 27: 125.
6. D'Incan M, Souteyrand P, Bignon Y, et al. Hydantoin-induced cutaneous pseudolymphoma with clinical, pathologic, and immunologic aspects of Sezary syndrome. Arch Dermatol 1992; 128: 1371.
7. Rosenthal C, Noguera C, Coppola A, et al. Pseudolymphoma with mycosis fungoides manifestations, hyper-responsiveness to diphenylhydantoin and lymphocyte dysregulation. Cancer 1982; 49: 2305.
8. Luelmo A, Mieras C, Martin-Urda M, et al. Generalized cutaneous B-cell pseudolymphoma induced by neuroleptics. Arch Dermatol 1992; 128: 121.
9. Rijlaarsdam J, Scheffer E, Meijer C, et al. Mycosis fungoides-like lesions associated with phenytoin and carbamazepine therapy. J Am Acad Dermatol 1991; 24: 216.
10. Magro C, Crowson A. Drugs with anti-histaminic properties as a cause of atypical cutaneous lymphoid hyperplasia. J Am Acad Dermatol 1995; 32: 419.
11. Jeng Y, Tien H, Su I. Phenytoin induced pseudolymphoma using modern molecular biology techniques. Epilepsia 1996; 37: 104.
12. Reed S, Glick J. Fluoxetine and the reactivation of the herpes simplex virus. Am J Psychiatry 1991; 49: 949.
13. Isaacson P, Wright D. Malignant lymphoma of mucosa-associated lymphoid tissue: a distinctive type of B-cell lymphoma. Cancer 1983; 52: 1410.
14. Bailey E, Ferry J, Harris N, Mihm M, Jacobson J, Duncan L. Marginal zone lymphoma (Low-grade B cell lymphoma of mucosa-associated lymphoid tissue type) of skin and subcutaneous tissue. Am J Surg Pathol 1996; 20: 1011.
15. Cerroni L, Zihling N, Putz B, Kerl H. Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J Cutan Pathol 1997; 24: 457.
16. Silvestri F, Barillari G, Fanin R et al. Hepatitis C virus infection among cryoglobulinemic and non-cryoglobulinemic B-cell non-Hodgkin's lymphomas. Haematologica 1997; 82: 314.
17. Aozasa K, Ohsawa M, Horiuchi K et al. The occurrence of monocytoid B-lymphocytes in autoimmune disorders. Mod Pathol 1993; 6: 121.
18. Hyjek E, Isaacson P. Primary B-cell lymphoma of the thyroid and its relationship to Hashimoto's thyroiditis. Hum Pathol 1988; 19: 1315.
19. Isaacson P, Spencer J. Malignant lymphoma and autoimmune disease. Histopathology 1993; 22: 509.
20. Isaacson P, Wright D. Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissue. Cancer 1984; 53: 2515.
21. Brandes L, LaBella F. Identification of intracellular histamine receptors (HIC) that regulate cell proliferation. Adv Biosci 1993; 89: 31.
22. Brandes L, Davie J, Paraskevas F, Sukhu B, Bogdanovic R, LaBella F. The antiproliferative potency of histamine antagonists correlates with inhibition of binding of 3H-histamine to novel intracellular receptors (HIC) in microsomal and nuclear fractions of rat liver. Agents Actions Suppl 1991; 33: 325.
23. Bluming A, Homer S, Khiroya R. Selective diphenylhyhantoin-induced suppression of lymphocyte reactivity in vitro. J Lab Clin Med 1976; 88: 417.